Guttormsen H K, Bjerknes R, Halstensen A, Naess A, Høiby E A, Solberg C O
Medical Department B, University of Bergen, Haukeland Hospital, Norway.
J Infect Dis. 1993 Jun;167(6):1314-9. doi: 10.1093/infdis/167.6.1314.
The opsonic activity of sera from healthy volunteers immunized with an outer membrane vesicle vaccine prepared from a Neisseria meningitidis (class 3, 44/76, B:15:P1.7,16), characteristic of the present Norwegian epidemic, has been examined. A marked increase in the phagocytosis of class 3 and nontypeable strains of different serogroups, serotypes, and serosubtypes was demonstrated in the presence of postvaccination sera. Sera from vaccinees also caused a significant increase in leukocyte oxidative metabolism as measured by luminol-enhanced chemoluminescence during phagocytosis of class 3 and nontypeable meningococci. An increase in serum opsonins cross-reacting with class 2 (type 2a) meningococci of different serogroups was not observed, suggesting that future meningococcal outer membrane vesicle vaccine preparations should contain both class 2 and class 3 porins in geographic areas where both class 2 and class 3 strains cause disease.
对来自健康志愿者的血清的调理活性进行了检测,这些志愿者接种了由挪威当前流行特征的脑膜炎奈瑟菌(3类,44/76,B:15:P1.7,16)制备的外膜囊泡疫苗。接种疫苗后的血清存在时,不同血清群、血清型和血清亚型的3类菌株和不可分型菌株的吞噬作用显著增加。通过鲁米诺增强化学发光法测定,接种疫苗者的血清在吞噬3类和不可分型脑膜炎球菌期间,白细胞氧化代谢也显著增加。未观察到与不同血清群的2类(2a型)脑膜炎球菌交叉反应的血清调理素增加,这表明在2类和3类菌株均引起疾病的地理区域,未来的脑膜炎球菌外膜囊泡疫苗制剂应同时包含2类和3类孔蛋白。